Meta-analysis for the value of colchicine for the therapy of pericarditis and of postpericardiotomy syndrome.
Leon L LutschingerAngelos G RigopoulosPeter SchlattmannMarios MatiakisDaniel SeddingPaul Christian SchulzeMichel NoutsiasPublished in: BMC cardiovascular disorders (2019)
Our meta-analysis confirms that colchicine is efficacious and safe for prevention of recurrent pericarditis and PPS, while it reduces rehospitalizations and symptom duration in pericarditis. The clinical use of colchicine for the setting of PPS and postoperative PE after heart surgery should be investigated in further multicenter RCT.